Dysregulated VEGF/VEGFR-2 Signaling and Plexogenic Lesions in the Embryonic Lungs of Chickens Predisposed to Pulmonary Arterial Hypertension

Lujie Ye,Rui Liu,Qinghao Li,Chunzhen Zhou,Xun Tan

DOI: https://doi.org/10.3390/ijms25084489

IF: 5.6

2024-04-20

International Journal of Molecular Sciences

Abstract:Plexiform lesions are a hallmark of pulmonary arterial hypertension (PAH) in humans and are proposed to stem from dysfunctional angioblasts. Broiler chickens (Gallus gallus) are highly susceptible to PAH, with plexiform-like lesions observed in newly hatched individuals. Here, we reported the emergence of plexiform-like lesions in the embryonic lungs of broiler chickens. Lung samples were collected from broiler chickens at embryonic day 20 (E20), hatch, and one-day-old, with PAH-resistant layer chickens as controls. Plexiform lesions consisting of CD133+/vascular endothelial growth factor receptor type-2 (VEGFR-2)+ angioblasts were exclusively observed in broiler embryos and sporadically in layer embryos. Distinct gene profiles of angiogenic factors were observed between the two strains, with impaired VEGF-A/VEGFR-2 signaling correlating with lesion development and reduced arteriogenesis. Pharmaceutical inhibition of VEGFR-2 resulted in enhanced lesion development in layer embryos. Moreover, broiler embryonic lungs displayed increased activation of HIF-1α and nuclear factor erythroid 2-related factor 2 (Nrf2), indicating a hypoxic state. Remarkably, we found a negative correlation between lung Nrf2 activation and VEGF-A and VEGFR-2 expression. In vitro studies indicated that Nrf2 overactivation restricted VEGF signaling in endothelial progenitor cells. The findings from broiler embryos suggest an association between plexiform lesion development and impaired VEGF system due to aberrant activation of Nrf2.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the relationship between the dysregulation of the vascular endothelial growth factor (VEGF) and its receptor 2 (VEGFR - 2) signaling pathway and the formation of plexiform lesions during the lung development of broiler embryos. Specifically, the research aims to:

1. **Observe the occurrence of plexiform lesions in the lungs of broiler embryos**: By collecting lung tissue samples of broiler chickens at different developmental stages (such as day 20 of the embryo, after hatching, and one day after birth), and using laying hens resistant to PAH as a control group, to observe whether plexiform lesions specifically occur in broiler embryos and how their density changes with the developmental stage.

2. **Analyze the differences in the VEGF/VEGFR - 2 signaling pathway between broiler chickens and laying hens**: Researchers compare the gene expression profiles of angiogenesis - related factors in the two chicken breeds, especially the expression of VEGF - A and VEGFR - 2, to explore the role of these molecules in the development of plexiform lesions.

3. **Explore the impact of VEGF/VEGFR - 2 signaling pathway inhibition on the development of plexiform lesions**: By pharmacologically inhibiting VEGFR - 2 activity, observe whether this inhibition can promote the development of plexiform lesions in laying hen embryos, thereby verifying the importance of the VEGF/VEGFR - 2 signaling pathway in lesion formation.

4. **Explore the relationship between Nrf2 activation and VEGF system dysfunction**: The study found that there is excessive activation of Nrf2 in the lungs of broiler embryos, which may be related to the decreased expression of VEGF - A and VEGFR - 2. Therefore, the study also explored the impact of Nrf2 over - expression on VEGF and VEGFR - 2 transcription and how this impact may lead to the development of plexiform lesions.

Through the above research, the authors hope to reveal the molecular mechanisms of plexiform lesion formation in broiler embryos, especially the roles of the VEGF/VEGFR - 2 signaling pathway and Nrf2 activation therein, thereby providing a new perspective for understanding the pathophysiological process of human PAH.